{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:06:34Z","timestamp":1784203594246,"version":"3.55.0"},"reference-count":14,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Gene fusions involving NUTM1 have been increasingly recognized in hematologic malignancies, though their role in acute myeloid leukemia (AML) remains poorly understood. We retrospectively analyzed 565 unique AML patients with reported fusion results who underwent comprehensive next-generation sequencing (NGS) between March 2022 and December 2023. Among them, three novel in-frame NUTM1 fusion transcripts, LARP1::NUTM1, ARHGAP15::NUTM1, and GABPB1::NUTM1, were identified in three relapsed or refractory AML cases, all with monocytic differentiation. Ancillary studies included flow cytometry, cytogenetics, FISH, and comprehensive mutational profiling. All three patients eventually relapsed and succumbed to their disease, despite initial responses in one case. Each case also harbored co-occurring mutations associated with adverse prognosis, such as BCOR, ASXL1, and RUNX1. These findings suggest NUTM1 fusions in AML could represent a distinct molecular subset with potentially poor prognosis, warranting further functional and clinical investigation to clarify their biological and therapeutic significance.<\/jats:p>","DOI":"10.3390\/ijms262311676","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:39:43Z","timestamp":1764679183000},"page":"11676","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel NUTM1 Fusions in Relapsed Acute Myeloid Leukemia: Expanding the Genetic and Clinical Landscape"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1928-8967","authenticated-orcid":false,"given":"Parastou","family":"Tizro","sequence":"first","affiliation":[{"name":"Pathology, Molecular Pathology and Therapy Biomarkers Division, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"},{"name":"Pathology, Hematopathology, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8879-9246","authenticated-orcid":false,"given":"Lisa","family":"Chang","sequence":"additional","affiliation":[{"name":"Pathology, Molecular Pathology and Therapy Biomarkers Division, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Salhotra","sequence":"additional","affiliation":[{"name":"Hematology and Transplant, Leukemia Division, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-4893","authenticated-orcid":false,"given":"Javier","family":"Arias-Stella","sequence":"additional","affiliation":[{"name":"Pathology, Molecular Pathology and Therapy Biomarkers Division, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8483-6988","authenticated-orcid":false,"given":"Milhan","family":"Telatar","sequence":"additional","affiliation":[{"name":"Pathology, Molecular Pathology and Therapy Biomarkers Division, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanina","family":"Tomasian","sequence":"additional","affiliation":[{"name":"Pathology, Molecular Pathology and Therapy Biomarkers Division, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Gaal","sequence":"additional","affiliation":[{"name":"Pathology, Hematopathology, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo","family":"Song","sequence":"additional","affiliation":[{"name":"Pathology, Hematopathology, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0606-899X","authenticated-orcid":false,"given":"Lorinda","family":"Soma","sequence":"additional","affiliation":[{"name":"Pathology, Hematopathology, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Fuentes","sequence":"additional","affiliation":[{"name":"Cytogenetics\/Cytogenomics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lino","family":"Garcia","sequence":"additional","affiliation":[{"name":"Cytogenetics\/Cytogenomics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Fei","sequence":"additional","affiliation":[{"name":"Pathology, Molecular Pathology and Therapy Biomarkers Division, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamaria","family":"Munteanu","sequence":"additional","affiliation":[{"name":"Pathology, Hematopathology, University of California, Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[{"name":"Hematology and Transplant, Leukemia Division, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5830-6158","authenticated-orcid":false,"given":"Michelle","family":"Afkhami","sequence":"additional","affiliation":[{"name":"Pathology, Molecular Pathology and Therapy Biomarkers Division, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"},{"name":"Pathology, Hematopathology, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"ref_1","unstructured":"Li, W. (2025, July 03). The 5th Edition of the World Health Organization Classification of Hematolymphoid Tumors, Leukemia [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK586208\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.3390\/curroncol28060381","article-title":"NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review","volume":"28","author":"Luo","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/PAS.0000000000001967","article-title":"Nutm1-rearranged carcinoma of the thyroid: A distinct subset of nut carcinoma characterized by frequent nsd3-nutm1 fusions","volume":"46","author":"Barletta","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1038\/s41375-021-01333-y","article-title":"Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study","volume":"35","author":"Boer","year":"2021","journal-title":"Leukemia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/bloodadvances.2020003007","article-title":"Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS","volume":"4","author":"Stengel","year":"2020","journal-title":"Blood Adv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"O207","DOI":"10.1111\/ijlh.13519","article-title":"Identification of a novel AVEN-NUTM1 fusion gene in acute myeloid leukemia","volume":"43","author":"Yuan","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1038\/onc.2014.428","article-title":"LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression","volume":"34","author":"Mura","year":"2015","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/15476286.2020.1744320","article-title":"LARP1 isoform expression in human cancer cell lines","volume":"18","author":"Schwenzer","year":"2021","journal-title":"RNA Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3960\/jslrt.20033","article-title":"Detection of novel and recurrent conjoined genes in non-Hodgkin B-cell lymphoma","volume":"61","author":"Matsumoto","year":"2021","journal-title":"J. Clin. Exp. Hematop."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Takagi, K., Miki, Y., Onodera, Y., Ishida, T., Watanabe, M., Sasano, H., and Suzuki, T. (2018). ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030804"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/gcc.23046","article-title":"NUTM1-fusion positive malignant neoplasms of the genitourinary tract: A report of six cases highlighting involvement of unusual anatomic locations and histologic heterogeneity","volume":"61","author":"Xu","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Xing, X., Mu, N., Yuan, X., Wang, N., Juhlin, C.C., Str\u00e5\u00e5t, K., Larsson, C., Neo, S.Y., and Xu, D. (2022). Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features. Cancers, 14.","DOI":"10.3390\/cancers14061385"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.scr.2016.04.007","article-title":"GABP is necessary for stem\/progenitor cell maintenance and myeloid differentiation in human hematopoiesis and chronic myeloid leukemia","volume":"16","author":"Manukjan","year":"2016","journal-title":"Stem Cell Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Wei","year":"2022","journal-title":"Blood"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11676\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:42:29Z","timestamp":1764679349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":14,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262311676"],"URL":"https:\/\/doi.org\/10.3390\/ijms262311676","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}